CA-MARY-KAY
24.2.2021 14:36:06 CET | Business Wire | Press release
Glamhive announced its fourth online conference to be held on February 27, 2021. The Glamhive Digital Winter Style and Beauty Summit will bring together top fashion and beauty leaders, from Kristen Bell's stylist to billion-dollar founder-turned female founder investor Cindy Eckert. The innovative leaders will discuss fashion, beauty, entrepreneurship, and more. Stephanie Sprangers and Nicole Chavez will co-host the event.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210224005275/en/
"I have loved being part of Glamhive's style & beauty summits, particularly during this challenging time. The summits have brought a sense of community, which is lacking in the world of creative talent, plus I have made some amazing connections with other artists along the way," said Nicole Chavez, celebrity stylist. Nicole is one of the most in-demand stylists today. Her clientele has ranged from A-List stars Kristen Bell, Rachel Bilson, Jessica Simpson, Ellie Bamber, Scarlett Johansson, Catherine Zeta-Jones, and many more. Her work has been featured in many publications, including W, InStyle, and Harper's Bazaar.
"Glamhive's vision is to give the benefits of working with a personal stylist available to everyone, everywhere, and our digital events are a wonderful extension of that. The silver lining of the past year is that it enabled us to pivot our style summits to digital, thereby making it possible for everyone, everywhere to meet and learn from the best in the business," said Stephanie Sprangers, Glamhive Founder and CEO. Sprangers is the Founder and Chief Executive Officer of Glamhive, the online personal styling service that brings expert personal stylists and makeup artists—recruited directly from Hollywood and Instagram—to everyone. Glamhive has developed proprietary software that allows stylists to take clients through a styling experience that is 100% online, allowing people to work with stylists anywhere in the world.
The all-day, ticketed event will feature over 60 speakers. Below is an overview of some of the topics that this all-star speaker line-up will cover.
TOPICS SNAPSHOT:
The day will consist of 22 segments across two-tracks. A snapshot:
- Red Carpet Style: Creating Iconic Style Moments
- 2021 Trends: Post-Pandemic Style
- Winning the Style Game: Vintage is Your Secret Weapon
- The Stylists Playbook: How to Get the Best Style of Your Life
- Beauty Boss Babe: An Interview with Jamie Kern Lima
- The Ultimate Guide to "Easy" Hair
- Let's Get Social: The Best Instagram and TikTok Beauty Trends
- The Astrology of Fashion: With Susan Miller
- More Than Meets the Eye: What Your Clothes Say About You
- The ROI of Style: How Dressing Well Pays Off
- How I Built This: Darn Good Advice from Women Who Made It to the Top
SPEAKERS:
Speakers include celebrity stylists, makeup artists, image-makers who work with the biggest names in Hollywood and beyond, including:
Angelina Jolie, Serena Williams, Mandy Moore, Sarah Jessica Parker, Kristen Bell, Khloe Kardashian, Robert Downey Jr., Keanu Reeves, Sharon Stone, Serena Williams, Miranda Lambert, Julianne Moore, and more.
CELEBRITY STYLISTS:
Nicole Chavez, Jill + Jordan, Jeanne Yang, Jennifer Rade, Tara Swennen, Janelle Miller, Lindsey Dupuis, Tiffany Gifford, Kesha McLoud, and Sonia Young.
CELEBRITY MAKEUP ARTISTS + HAIRSTYLISTS:
Tommy Buckett, Todd Harris, Diana Madison, Danny Moon, AJ Crimson, and Helen Reavey.
ENTREPRENEURS, DESIGNERS, AND BUSINESS LEADERS:
Claire Sulmers (Fashion Bomb Daily), Hillary Kerr (WhoWhatWear), Tara Rudes Dann (L'Agence), Steven Dann (Designer), Cindy Eckert (The Pink Ceiling Fund), Helen Ravey (Act+Acre), Cassandra Cadwell (Violet Grey), Michelle Waugh (Designer), Clarissa Egana (Port De Bras), Amy Rosoff Davis (Celebrity Trainer), Jamie Kern Lima (IT Cosmetics).
MODERATORS:
Brian Underwood (O Magazine), Brooke Jaffe (Penske Media), Pandora Amoratis (Daily Mail), Andrea Lavanthal (PEOPLE), Robin Nazzaro (O Magazine), Alexis Bennett (Vogue) and Kibwe Chase-Marshall (The Kelly Initiative).
Tickets to the conference are $149 for an all-day ticket. The Glamhive Digital Winter Style and Beauty Summit's presenting sponsor is Mary Kay Inc. and its Mary Kay Global Design Studio.
For more information, visit www.glamhive.com/upcoming .
About Glamhive
Glamhive was founded by entrepreneur Stephanie Sprangers in 2017 with the vision to democratize personal styling and the premise that the confidence that comes with glamour should not be exclusive to the rich and famous.
The online styling experience offers anyone with a WiFi connection access to stylists who will provide them with the support they need to be the best version of themselves. The Glamhive platform is a seamless end-to-end platform for stylists to help them grow their network and their business, 100% virtually.
About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company more than 57 years ago with three goals: develop rewarding opportunities for women, offer irresistible products, and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skin care, color cosmetics, nutritional supplements and fragrances. Mary Kay is committed to empowering women and their families by partnering with organizations from around the world, focusing on supporting cancer research, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Mary Kay Ash’s original vision continues to shine—one lipstick at a time. Learn more at MaryKay.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210224005275/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Merz Therapeutics Announces Completion of Recruitment in Two Phase III Trials Investigating XEOMIN® (incobotulinumtoxinA) for Migraine Prevention15.10.2026 08:00:00 CEST | Press release
Patient recruitment completed six months ahead of schedule in two global Phase III trials for migraine prevention MINT-E and MINT-C are evaluating XEOMIN® (incobotulinumtoxinA) for the preventive treatment of episodic and chronic migraine Trials recruited approximately 1,800 adults across 109 study sites in North America and Europe Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, today announced the completion of patient recruitment in two global Phase III clinical trials, MINT-E (NCT07018700) and MINT-C (NCT07018713), evaluating the efficacy and safety of XEOMIN® (incobotulinumtoxinA) for the prevention of episodic and chronic migraine in adults. The trials recruited approximately 1800 adults across 109 study sites in North America and Europe. Migraine affects around 1.1 billion people worldwide, posing a significant burden on patients, society and healthcare systems.1 Both trials are evaluating the change in monthly migraine days from baseline to Month
Tourism Malaysia and Alipay+ Partner to Accelerate Malaysia’s Digital Tourism Transformation15.10.2026 07:10:00 CEST | Press release
Collaboration will connect seamless payments, in-app digital engagement and AI-powered travel services to enhance the visitor journey, empower businesses of all sizes and unlock wider cross-border commerce opportunities Tourism Malaysia and Alipay+, the unified wallet gateway of Ant International, today signed a Memorandum of Understanding (MoU) to accelerate cross-border commerce and digitalise merchant engagement across Malaysia's tourism economy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261014035900/en/ (From left) Mr Mohd Akbal Setia (Head of VM2026 Secretariat and Senior Director, Advertising & Digital Tourism); Mr Mohd Amirul Rizal Abdul Rahim (Director General, Tourism Malaysia); Mr Danny Chung (General Manager of Alipay+ Global Growth Center and Vice President of Ant International); Mr Michael Guo, Alipay+ General Manager of SEA, South Asia and ANZ, Ant International) As Malaysia welcomes visitors for Visit Mal
PeDRA 2026: Nemolizumab Phase II Data Show Long-Term Symptom Relief for Children Aged 2 to 11 Years With Moderate-to-Severe Atopic Dermatitis15.10.2026 07:00:00 CEST | Press release
Patient-reported outcomes from a phase II study of nemolizumab in children aged 2 to 11 with moderate-to-severe atopic dermatitis show meaningful reductions in itch severity, better sleep and improved quality of life, maintained for a year1 Currently, there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis, despite the high unmet need – the disease can significantly reduce quality of life for children and create burden on their families2-8 These findings expand on the clinical evidence base for nemolizumab, which has multiple global approvals for adult and pediatric patients 12 years of age and older with moderate-to-severe atopic dermatitis, and adults with prurigo nodularis9,10 Galderma (SIX: GALD), the pure-play dermatology category leader, today announced new phase II data showing that nemolizumab provided meaningful improvements in itch, sleep disturbance, and quality of life in children aged 2 to 11 years with moderate-to-severe
Takeda’s ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 115.10.2026 02:30:00 CEST | Press release
− ORZEYFUL is now available in Japan and China following approvals within a month of each other by China’s National Medical Products Administration (NMPA), the U.S. Food and Drug Administration (FDA) and Japan’s Ministry of Health, Labour and Welfare (MHLW) − Discovered by Takeda scientists in Japan, ORZEYFUL is the lead medicine in Takeda’s orexin franchise, with multiple programs for sleep-wake disorders and conditions where orexin biology plays a role − ORZEYFUL set to launch next month in the U.S., following completion of DEA scheduling; Health Authority submissions underway worldwide Takeda (TSE:4502/NYSE:TAK)announced today that ORZEYFUL (oveporexton) is now available in Japan and China for the treatment of narcolepsy type 1 (NT1), providing first access to clinicians to prescribe treatment with the new class of medicine. ORZEYFUL is a first-in-class orexin receptor 2 (OX2R) agonist, in tablet form, designed to treat the underlying orexin deficiency associated with NT1. “We’re ex
Celltrion to Spotlight Subcutaneous (SC) Infliximab (Remsima™ SC) and Broader IBD Portfolio at UEG Week 202615.10.2026 02:10:00 CEST | Press release
Celltrion to showcase its broad IBD portfolio, including Remsima™ IV, Remsima™ SC, the newly launched Remsima™ IV Liquid formulation, Steqeyma™ and Yuflyma™Symposium and Meet the Experts sessions to highlight long-term clinical evidence and real-world experience with subcutaneous (SC) infliximab (Remsima™ SC) across different IBD patient scenarios Celltrion, Inc. (KRX:068270) announced its participation in United European Gastroenterology (UEG) Week 2026, in Barcelona, Spain (Oct. 17-20), highlighting its inflammatory bowel disease (IBD) treatment portfolio, led by Remsima™ SC (subcutaneous infliximab). Celltrion will showcase its comprehensive infliximab portfolio, comprising Remsima™ intravenous (IV) and subcutaneous (SC) formulations, as well as the Remsima™ IV liquid formulation launched in Europe earlier this year.1 Additionally, the company will highlight its broader IBD portfolio, including SteQeyma™ (ustekinumab) and Yuflyma™ (adalimumab), reflecting its continued efforts to ex
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom